Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Br J Haematol. 2015 Mar 30;170(1):56–65. doi: 10.1111/bjh.13389

Table Va. NPV of Mid-Treatment PET According to IPI Risk Group.

IPI risk group Patients with negative mid-treatment PET
(N=57)		 Patients progression-free at 2 years
(N=43)		 NPV of mid-Treatment PET Scan
(90% CI)
Low (0-1) 11 8 73% (44-92%)
Low intermediate (2) 14 11 79% (53-94%)
High intermediate (3) 19 14 74% (52-89%)
High (4-5) 13 10 77% (51-93%)
Total 57 43 75% (64-84%)
*

Patients who were mid-treatment PET-negative and who had known 2-year progression-free survival status (i.e., not censored before 2 years) were included in the table.